Reforgene Medicine
Guangzhou
About Reforgene Medicine
Reforgene Medicine is a biomedical company that uses gene editing and genomic technology to develop new drugs intended to cure genetic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $30.1M
- Last round: Series Unknown (Dec 2024)
- Website: reforgene.com
- Phone: 86 20 31702930
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/reforgene-medicine-34917 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.